Public
ST PHARM News

ST PHARM's Public Release

ST PHARM NewsST PHARM, FDA cGMP certification for oligo plant in Korea, for the first time in AsiaAug 2, 2022
ST PHARM NewsST PHARM 'STP1002' Preclinical Result EJC PublishedJul 19, 2022
ST PHARM NewsST PHARM Acquired EcoVadis Silver Grade CertificationJul 11, 2022
ST PHARM NewsST PHARM Announces HIV-1 / AIDS Treatment Drug 'STP0404' Phase 1 Clinical Trial Results 'Positive and Safe'Jul 6, 2022
ST PHARM NewsST PHARM, Awarded 2022 Asia-Pacific Oligonucleotide CDMO Campany by Frost & SullivanMay 2, 2022
ST PHARM NewsST PHARM, Participated in TIDES USA 2022 Conference As a Gold sponsorMay 2, 2022
ST PHARM NewsST PHARM to Expand Oligonucleotide FacilityNov 29, 2021
ST PHARM NewsST PHARM Announces Expansion of Oligonucleotide Facility, Taking a Leap Towards the World's Largest Oligonucleotide CDMONov 29, 2021
ST PHARM NewsST PHARM Announces Publication of Preclinical Data for HIV-1 / AIIDS Treatment Drug 'STP0404'Jul 22, 2021
ST PHARM NewsST PHARM, The First Company Developing mRNA-LNP Vaccine in South KoreaJun 1, 2021
4of3
HOMEPublicPR (Public Relations)News roomST PHARM News
© 2024 ST Pharm. All rights reserved.